Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity

Sean Wharton

Ildiko Lingvay

Department of Internal Medicine and Endocrinology, University of Texas Southwestern Medical Center, Dallas

Pawel Bogdański

Department of Obesity Treatment, Metabolic Disorders, and Clinical Dietetics, Poznan University of Medical Sciences, Poznan, Poland

Ruben Duque do Vale

Novo Nordisk, Søborg, Denmark

Stephan Jacob

Department of Internal Medicine, Endocrinology, and Diabetology, Cardiometabolic Institute, Villingen-Schwenningen, Germany

Tobias Karlsson

Novo Nordisk, Søborg, Denmark

Chaithra Shaji

Novo Nordisk Global Business Services, Bangalore, India

Domenica Rubino

Washington Center for Weight Management and Research, Arlington, VA

W. Timothy Garvey

Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham